Obesity Algorithm (2017 - 2018) Sneak Peek

Table of Contents

Obesity Algorithm 5 Chronic Disease of Obesity . . . . . . . . . . . . . . . . . . . . . 7 Genetics . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Obesity Classification 17 Fat Mass Disease . . . . . . . . . . . . . . . . . . . . . . . 21 Adiposopathy (Sick Fat Disease) . . . . . . . . . . . . . . . . . 25 Obesity Paradox . . . . . . . . . . . . . . . . . . . . . . . 30 Stress and Obesity . . . . . . . . . . . . . . . . . . . . . . 38 Assessment and Evaluation 41 Patient History . . . . . . . . . . . . . . . . . . . . . . . 42 Physical Exam 45 Laboratory and Diagnostic Testing . . . . . . . . . . . . . . . 46 Body Composition . . . . . . . . . . . . . . . . . . . . . . 48 Energy Expenditure . . . . . . . . . . . . . . . . . . . . . 54 Concomitant Medications 59 Nutrition 63 Physical Activity 77 Behavior 81 Motivational Interviewing . . . . . . . . . . . . . . . . . . . 82 Behavioral Therapy 91 Technologies for Weight-management . . . . . . . . . . . . . . 103 Medication . . . . . . . . . . . . . . . . . . . . . . . . . . . 105 Lorcaserin . . . . . . . . . . . . . . . . . . . . . . . . . 110 Phentermine HCI/Topiramate Extended Release . . . . . . . . . . 112 Naltrexone HCI/Bupropion HCL Extended Release 114 Liraglutide . . . . . . . . . . . . . . . . . . . . . . . . . 116 Early Versus Late Weight-management Intervention . . . . . . . . . 119 Illustrative Consequences . . . . . . . . . . . . . . . . . . . 119 Bariatric Surgery 123 Executive Summary 155 References . . . . . . . . . . . . . . . . . . . . . . . . . . . 159

4